Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping

NCT06244082 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

DMD
Duchenne Muscular Dystrophy
Duchenne
Exon 44

Interventions

DRUG: AOC 1044

Sponsor

Avidity Biosciences, Inc.